Search

Reglagene Selected to Participate in Johnson & Johnson Innovation Quick Pitch

Updated: Feb 27, 2020

Reglagene was one of 10 companies selected out of more than 300 applicants to pitch leaders from across Johnson & Johnson Innovation during the 2019 J.P. Morgan Healthcare Conference. JPM Week occurs annually in January and is the largest gathering of the pharma, biotech, and investor sectors. Johnson & Johnson Innovation launched the Quick Pitch to unearth the unseen and brightest innovations in healthcare. During the event on January 9, 2019, Reglagene made a tightly woven and compelling presentation that also served as the basis for conversations with prospective investors and pharmaceutical partners throughout the week. After the presentation, Johnson & Johnson awarded Reglagene a trophy for its participation. Reglagene’s CSO Laurence Hurley and CEO Richard Austin proudly pose with the prize.


Recent Posts

See All

Reglagene Featured on KGUN News!

"That's what we want to do. That is the dream: to irreversibly cure people's cancer," said Richard Austin, the CEO and Co-Founder of Reglagene. Reglagene was featured on KGUN news today!

Reglagene Featured in the Arizona Daily Star!

Reglagene was featured in the Arizona Daily Star! Director of Biology Teri Suzuki and Business Development Manager Michael Abrahamson were interviewed. Click here to read the full article and intervie

OFFICE

1703 E Mabel St
Tucson, AZ 85721
USA

www.reglagene.com  |  https://www.linkedin.com/company/reglagene/ | ©2020 by Reglagene Holding, Inc.